Position in ACB
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$19
-$3 QoQ
Shares Held
7
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#106
of 149 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ACB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Coston, McIsaac & Partners holds $48,181 across 6 Drug Manufacturers - Specialty & Generic names. ACB ranks #6 (0.0% of the industry book) .
All Filings in ACB
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19 | 7 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $22 | 7 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $29 | 7 | Shares | Sole | 2026-02-03 | |
| No filing history on record for this holder in this stock. | ||||||